Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue-and schedule-induced reinstatement of nicotine self-administration behavior in rats

AY Bespalov, OA Dravolina, I Sukhanov… - …, 2005 - Elsevier
Previous studies suggested that metabotropic glutamate 5 (mGlu5) receptors play an
important role in the reinforcing effects of abused drugs. The present experiments evaluated …

Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals

M Marchi, M Grilli, AM Pittaluga - Frontiers in Pharmacology, 2015 - frontiersin.org
This review focuses on a specific interaction occurring between the nicotinic cholinergic
receptors (nAChRs) and the glutamatergic receptors (GluRs) at the nerve endings level. We …

Neuroadaptive changes in the mesocortical glutamatergic system during chronic nicotine self‐administration and after extinction in rats

F Wang, H Chen, BM Sharp - Journal of neurochemistry, 2008 - Wiley Online Library
Nicotine self‐administration causes adaptation in the mesocorticolimbic glutamatergic
system, including the up‐regulation of ionotropic glutamate receptor subunits. We therefore …

Neurobiological mechanisms of nicotine reward and aversion

L Wills, JL Ables, KM Braunscheidel, SPB Caligiuri… - Pharmacological …, 2022 - ASPET
Neuronal nicotinic acetylcholine receptors (nAChRs) regulate the rewarding actions of
nicotine contained in tobacco that establish and maintain the smoking habit. nAChRs also …

New mechanisms and perspectives in nicotine withdrawal

KJ Jackson, PP Muldoon, M De Biasi, MI Damaj - Neuropharmacology, 2015 - Elsevier
Diseases associated with tobacco use constitute a major health problem worldwide. Upon
cessation of tobacco use, an unpleasant withdrawal syndrome occurs in dependent …

Regional cerebral glutamate concentrations and chronic tobacco consumption

J Gallinat, F Schubert - Pharmacopsychiatry, 2007 - thieme-connect.com
Introduction: Increasing evidence indicates a crucial role of glutamate in the brain reward
system and nicotine addiction. Because the pertinent models involve frontal and …

Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats

TJ Hopkins, LE Rupprecht, MR Hayes… - …, 2012 - nature.com
Current smoking cessation pharmacotherapies have limited efficacy in preventing relapse
and maintaining abstinence during withdrawal. Galantamine is an acetylcholinesterase …

The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a …

MS D'souza, ME Liechti, AM Ramirez-Nino… - …, 2011 - nature.com
Abstract The metabotropic glutamate 2/3 (mGlu2/3) receptor agonist LY379268 ([−]-2-oxa-4-
aminobicyclo [3.1. 0] hexane-4, 6-dicarboxylate) attenuates both nicotine self-administration …

Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction

NL Benowitz - Clinical Pharmacology & Therapeutics, 2008 - Wiley Online Library
Understanding the basic and clinical pharmacology of nicotine provides a basis for
improved prevention and treatment of tobacco addiction. Nicotine acts on nicotinic …

Nicotine dependence—human and animal studies, current pharmacotherapies and future perspectives

M Zaniewska, E Przegaliński, M Filip - Pharmacological Reports, 2009 - Springer
Nicotine dependence is a disease of constantly growing importance. This mini-review
describes the effects of nicotine in humans and focuses on the various laboratory animal …